Personas / Equipo Humano

Antoni Noguera Julian

Buscador de publicaciones

Publicaciones

  • Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño MA, García Del Toro M, Hita C, Gómez-Sirvent JL, Buzón L, Díaz de Santiago A, Pérez Arellano JL, Sanz J, Bachiller P, Martínez Alfaro E, Diaz de Brito V, Masiá M, Hernández-Torres A, Guerra J, Santos J, Arazo P, Muñoz L, Arribas JR, Martínez de Salazar P, Moreno S, Hernán MA, Del Amo J, Del Amo J, Rosa Polo, Moreno S, Berenguer J, Martínez E, Hernán M, Martínez de Salazar P and García de Albéniz X.

    Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers.

    CLINICAL MICROBIOLOGY AND INFECTION . 29(1): 85-93. Nº de citas: 9

    [doi:10.1016/j.cmi.2022.07.006]

  • Calzada-Hernández J, Anton-Lopez J, Martín-de-Carpi J, López-Montesinos B, Calvo I, Donat E, Núñez E, Blasco Alonso J, Mellado MJ, Baquero-Artigao F, Leis R, Vegas-Álvarez AM, Medrano San Ildefonso M, Pinedo-Gago MDC, Eizaguirre FJ, Tagarro A, Camacho-Lovillo M, Pérez-Gorricho B, Gavilán-Martín C, Guillén S, Sevilla-Pérez B, Peña-Quintana L, Mesa-Del-Castillo P, Fortuny-Guasch C, Tebruegge M and Noguera-Julian A.

    Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-a inhibitor initiation in children in Spain

    EUROPEAN JOURNAL OF PEDIATRICS . 182(1): 307-317. Nº de citas: 10

    [doi:10.1007/s00431-022-04640-3]

  • Soler-García a, Gamell A, Pérez-Porcuna T, Soriano-Arandes A, Begoña Santiago García, Tórtola T, Ruiz-Serrano MJ, Korta Murua JJ, Bustillo-Alonso M, Garrote-Llanos MI, Rodríguez-Molino P, Piqueras AI, Tagarro A, Manuel Monsonis Cabedo, Tebruegge M, Noguera-Julian A and QFT-Plus Study Group of the Spanish Pediatric TB Research Network.

    Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study

    Thorax . 77(12): 1193-1201. Nº de citas: 11

    [doi:10.1136/thoraxjnl-2021-217592]

  • Velasco E, Batllori-Tragant M, Manuel Monsonis Cabedo, Valls-Lafon A, Rios-Barnés M, Simó-Nebot S, Gamell Fullà A, Fortuny-Guasch C, Tebruegge M and Noguera-Julian A.

    Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5 years of age

    SCIENTIFIC REPORTS . 12(1): 19908-19908. Nº de citas: 2

    [doi:10.1038/s41598-022-24433-w]

  • Aguilera-Alonso, D, Solis-Garcia, G, Noguera-Julian A, Gonzalez-Martin, J, Cobena, AR, Baquero-Artigao, F, Rueda, CT, Rodriguez-Molino, P, Sanchez, IB, Vallmanya, T, Bernet-Sanchez, A, Domingo, LM, Rubio, A, Saavedra-Lozano, J, Ruiz-Serrano, MJ, Blazquez-Gamero, D, Lopez-Roa, P, Gomez-Pastrana, D, Prieto, MDL, Medina, EML, Gil-Brusola, A, Nalda, AM, Soriano-Arandes, A, Tortola, T, Falcon-Neyra, L, Galan, VG, Tebruegge, M and Santiago-Garcia, B.

    Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

    Thorax . 77(10): 1023-1029. Nº de citas: 9

    [doi:10.1136/thorax-2021-218378]

  • Torres-Fernandez D, Jiménez de Ory S, Fortuny-Guasch C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á and Prieto L.

    Integrase inhibitors in children and adolescents: clinical use and resistance

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(10): 2784-2792. Nº de citas: 3

    [doi:10.1093/jac/dkac259]

  • Turkova A, Waalewijn H, Chan MK, Bollen PDJ, Bwakura-Dangarembizi MF, Kekitiinwa AR, Cotton MF, Lugemwa A, Variava E, Ahimbisibwe GM, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo CM, Archary M, Ferrand RA, Violari A, Gibb DM, Burger DM, Ford D and Colbers A.

    Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

    Lancet HIV . 9(9): 627-637. Nº de citas: 17

    [doi:10.1016/S2352-3018(22)00160-6]

  • Amuge P, Lugemwa A, Wynne B, Mujuru HA, Violari A, Kityo CM, Archary M, Variava E, White E, Turner RM, Shakeshaft C, Ali S, Nathoo KJ, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa AR, Giaquinto C, Rojo P, Gibb DM, Turkova A and Ford D.

    Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

    Lancet HIV . 9(9): 638-648. Nº de citas: 17

    [doi:10.1016/S2352-3018(22)00163-1]

  • Thee S, Basu Roy R, Blázquez-Gamero D, Falcón-Neyra L, Neth O, Noguera-Julian A, Lillo C, Galli L, Venturini E, Buonsenso D, Götzinger F, Martinez-Alier N, Velizarova S, Brinkmann F, Welch SB, Tsolia M, Santiago-Garcia B, Schilling R, Tebruegge M, Krüger R and ptbnet TB Meningitis Study Group.

    Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study

    CLINICAL INFECTIOUS DISEASES . 75(3): 372-381. Nº de citas: 18

    [doi:10.1093/cid/ciab982]

  • Villaverde S, Esquivel E, Baquero-Artigao F, Noguera-Julian A, Frick MA, Rojo P, Blázquez-Gamero D and Spanish Registry of Children with Congenital CMV.

    Impact of the COVID-19 Pandemic on the Diagnosis of Congenital Cytomegalovirus Infection in Spain

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 41(7): 590-592. Nº de citas: 4

    [doi:10.1097/INF.0000000000003532]